StockData
Kairos Pharma, LTD. logo

Kairos Pharma, LTD. (KAPA) stock

KAPANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.44+0.04 (+10.08%)

Close on Nov 18, 2026Market cap $1.64MP/E –Yield –

Kairos Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Kairos Pharma's market cap was $10.92M on Nov 11, 2026, against $121.51M a year earlier. Over the last 2 years it ranged from $10.92M to $167.68M, with a median of $90.02M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$10.92M-89.4%
2025Dec 31, 2025$103.48M-24.3%
2024Dec 31, 2024$136.69M–

More Kairos Pharma figures

See a number that looks wrong?